<SEC-DOCUMENT>0001171843-19-004410.txt : 20191007
<SEC-HEADER>0001171843-19-004410.hdr.sgml : 20191007
<ACCEPTANCE-DATETIME>20190703160023
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001171843-19-004410
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20190703

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Capstone Therapeutics Corp.
		CENTRAL INDEX KEY:			0000887151
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				860585310
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		1275 WEST WASHINGTON STREET
		STREET 2:		SUITE 101
		CITY:			TEMPE
		STATE:			AZ
		ZIP:			85281
		BUSINESS PHONE:		6022865520

	MAIL ADDRESS:	
		STREET 1:		1275 WEST WASHINGTON STREET
		STREET 2:		SUITE 101
		CITY:			TEMPE
		STATE:			AZ
		ZIP:			85281

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ORTHOLOGIC CORP
		DATE OF NAME CHANGE:	19940211
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><IMG SRC="logo.jpg" ALT=""></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0pt 0; font-size: 10pt">July 3, 2019</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">David M. Plattner</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">Special Counsel</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">Office of Mergers &amp; Acquisitions</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">Securities and Exchange Commission</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">Division of Corporate Finance</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 11%; text-align: center"><B>Re:</B></TD>
    <TD STYLE="width: 84%"><B>Capstone Therapeutics Corp.</B></TD>
    <TD STYLE="width: 5%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD><B>Schedule 13E-3 filed by Capstone Therapeutics Corp.</B></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD><P STYLE="margin-top: 0; margin-bottom: 0"><B>Filed May 31, 2019</B></P>
        <P STYLE="margin-top: 0; margin-bottom: 0"><B>File No. 005-42745</B></P></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD><P STYLE="margin-top: 0; margin-bottom: 0"><B>Preliminary Proxy Statement on Schedule 14A</B></P>
        <P STYLE="margin-top: 0; margin-bottom: 0"><B>Filed May 31, 2019</B></P>
        <P STYLE="margin-top: 0; margin-bottom: 0"><B>File No. 000-21214</B></P></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt"><B></B></P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-indent: 0.5in"></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">Dear Mr. Plattner:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Capstone Therapeutics Corp. (the &ldquo;Company&rdquo;) is submitting
this letter in response to the written comments of the staff (the &ldquo;Staff&rdquo;) of the Securities and Exchange Commission
(the &ldquo;Commission&rdquo;), dated June 27, 2019, with respect to the Company&rsquo;s Schedule 13E-3 filed with the Commission
on May 31, 2019 (File No. 005-42745) and the Company&rsquo;s Preliminary Proxy Statement on Schedule 14A filed with the Commission
on May 31, 2019 (File No. 000-21214). Each of the Staff&rsquo;s comments is set forth below, followed by the Company&rsquo;s corresponding
response. For ease of reference, the headings and numbered paragraphs below correspond to the headings and numbered comments in
the Staff&rsquo;s comment letter. The references in our responses are to, as applicable, the amended Preliminary Proxy Statement
(the &ldquo;Amended Proxy Statement&rdquo;) and the amended Schedule 13E-3, which are being filed today by electronic submission.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Capitalized terms used and not defined herein have the meanings
given in the Amended Proxy Statement.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"><B><U>Schedule 13E-3 </U></B></P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>1.</I></B></TD><TD><B><I>Please advise us as to what consideration has been given to whether BP Peptides, LLC, Mr. Toporek, and Mr. Lipman are
affiliates engaged in the going private transaction and, accordingly, should be filing persons on the Schedule 13E-3. Alternatively,
please revise the Schedule 13E-3 to include such parties as filing persons. </I></B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><B>Response</B>:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Company respectfully advises the Staff that the Company considered
a number of factors in determining whether BP Peptides, LLC, Mr. Toporek, and Mr. Lipman are affiliates engaged in the going private
transaction. In particular, the Company notes to the Staff that there will be no special treatment for BP Peptides, LLC, Mr. Toporek
and Mr. Lipman in the transaction. In addition, the Company is paying for the expenses in connection with the reverse stock split,
including the Cash-Out Payment. Lastly, the impact of the reverse stock split on the percentage ownership of Continuing Stockholders,
including BP Peptides, LLC, Mr. Toporek and Mr. Lipman, will be negligible. Accordingly, BP Peptides, LLC, Mr. Toporek, and Mr.
Lipman are not deemed to be engaged in the transaction and, thus, are not required to file a Schedule 13E-3 in connection with
the transaction.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><IMG SRC="footer.jpg" ALT=""></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><IMG SRC="logo.jpg" ALT=""></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"><B><U>Preliminary Proxy Statement on Schedule 14A<BR>
<BR>
</U></B></P>

<P STYLE="margin: 0pt 0; font-size: 10pt"><U>Summary of Terms of Reverse Stock Split, page 4 </U></P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>2.</I></B></TD><TD><B><I>We note the disclosure on page 4 and elsewhere that states that you &ldquo;currently anticipate&rdquo; that in lieu of
issuing fractional shares, you will aggregate all fractional shares and have your exchange agent sell the aggregated amount. Please
explain why this is phrased merely as an expectation and what circumstances would lead to a different result. </I></B></TD></TR></TABLE>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-indent: -0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><B>Response</B>:<BR>
<BR>
</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">The Company respectfully notes to the Staff that certain logistical actions to be taken
pertaining to the fractional shares relate to the Company&rsquo;s agreement with its exchange agent, Computershare, and Computershare&rsquo;s
ability provide the applicable services. The Company&rsquo;s agreement with Computershare gives Computershare the right to cancel
such agreement for any reason with 30-days-notice. However, the Company is currently unaware of any reason for such cancellation
by Computershare and does not anticipate Computershare to do. In the unlikely event that Computershare were to cancel the agreement,
the Company would seek to engage an alternative exchange agent. To provide clarification, the Company has revised the disclosures
on pages 4 and 12 of the Amended Proxy Statement to replace the &ldquo;currently anticipate&rdquo; language as set forth below
(new language is shown in underline):</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt">&ldquo;<U>Subject to our agreement with our exchange agent</U>, in lieu of
issuing fractional shares, the aggregate of all fractional shares otherwise issuable to the holders of record of Common Stock shall
be issued to our exchange agent for the Common Stock, as agent, for the accounts of all holders of record of Common Stock otherwise
entitled to have a fraction of a share issued to them.&rdquo;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>3.</I></B></TD><TD><B><I>We note the disclosure on page 4 and elsewhere that indicates that the sale of the aggregated fractional interests will
occur &ldquo;as soon as practicable&rdquo; after the Effective Date on the basis of prevailing market prices of the Common Stock
at the time of sale. Please be more precise about the timing of such sale. </I></B></TD></TR></TABLE>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-indent: -0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><B>Response</B>:<BR>
<BR>
</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">The Company respectfully acknowledges the Staff&rsquo;s comment and has added additional
language on pages 4 and 12 of the Amended Proxy Statement to clarify that the Company expects that its exchange agent will conduct
the sale in an orderly fashion at a reasonable pace and that it may take several days to sell all of the aggregated fractional
shares of common stock.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>4.</I></B></TD><TD><B><I>We note the disclosure on page 4 that refers to the payment of net proceeds to shareholders &ldquo;after customary brokerage
commissions and other expenses.&rdquo; At the bottom of page 8, however, the disclosure states that the Reverse Stock Split will
allow liquidation by small stockholders of their shares &ldquo;without having to pay brokerage commissions.&rdquo; Please reconcile
these two apparently contradictory statements. </I></B></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><B>Response</B>:<BR>
<BR>
</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">The Company respectfully acknowledges the Staff&rsquo;s comment and notes to the Staff
that the intent of the language at the bottom of page 8 was to convey that the reverse stock split will allow small stockholders
to liquidate shares of common stock at a market price without having to directly pay full brokerage fees. Many of the affected
stockholders hold 200 or fewer shares, making brokerage fees to sell those shares greater than the price of the shares. When the
fractional interests are aggregated and sold by Computershare, there will be brokerage fees, but those fees should be proportionally
much less for the affected stockholders. The Company has revised the disclosure on page 8 of the Amended Proxy Statement to clarify
this point.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><IMG SRC="footer.jpg" ALT=""></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><IMG SRC="logo.jpg" ALT=""></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"><U>Alternatives Considered, page 15 </U></P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>5.</I></B></TD><TD><B><I>We note the disclosure that states, &ldquo;The Board considered issuer purchases, e.g., by tender offer, but concluded
that the Company did not have sufficient resources to effectuate such purchases at the level that would reduce record stockholders
to below 300.&rdquo; Please provide additional detail as to why such alternative transactions would require resources beyond what
is required to effectuate the Reverse Stock Split. </I></B></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><B>Response</B>:<BR>
<BR>
</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">The Company respectfully advises the Staff that a tender offer transaction would potentially
involve increased expenses compared to a reverse stock split, including higher legal costs and other transactional expenses, in
addition to uncertainty in whether such transaction would result in less than 300 stockholders of record. The Company has revised
the disclosure on page 15 of the Amended Proxy Statement to clarify this point.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"><U>Fairness of the Reverse Stock Split, page 15<BR>
<BR>
</U></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>6.</I></B></TD><TD><B><I>We note the disclosure on page 16 that states, &ldquo;The Board believes the Cash-Out Payment is fair to our stockholders
as it is based on the arms-length trading activity as reported on the OTCQB stock exchange.&rdquo; Elsewhere the disclosure speaks
to the likelihood of the Reverse Stock Split resulting in a negative impact on the market price and trading activity of the Common
Stock following the Effective Date (see, e.g., &ldquo;Disadvantages of the Reverse Stock Split&rdquo; on pages 14-15). Please explain
how the Board has been able reasonably to conclude that the Cash-Out Payment will be fair when (i) the Cash-Out Payment is unknown
until after the Reverse Stock Split occurs, (ii) by its very nature the Reverse Stock Split is likely to drive down the value of
the Cash-Out Payment, (iii) no downside protection in favor of cashed-out shareholders appears to have been built into the pricing
mechanism in the event that the market price does indeed decline following the Effective Date, and (iv) there do not appear to
be any specific timing constraints associated with the Company&rsquo;s obligation to effect the sale of the aggregated fractional
shares and disburse the Cash-Out Payment. </I></B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><B>Response</B>:<BR>
<BR>
</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Company respectfully advises the Staff that the Board considered
a number of factors in concluding that the Cash-Out Payment is fair to the Cashed-Out Stockholders. In particular, the Company
notes to the Staff:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">While the Cash-Out Payment will not be known until after the reverse stock split occurs, it is
entirely speculative whether the trading price of the common stock will be up or down following the reverse stock split. A decline
in price is certainly a possibility but it is by no means the assured outcome, especially given the low trading volume of the common
stock and the possibility that the reverse stock split and related going private transaction may be viewed favorably in light of
the potential benefits described in the proxy statement. The Board thus focused on a &ldquo;fair process&rdquo; and determined
that an aggregation and sale by an independent party on the established OTCQB market is a fair process for determining the value
of the stock.</TD></TR></TABLE>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Regardless of the Cash-Out Payment amount, Cashed-Out Stockholders will still receive the CVRs
since they will have been stockholders as of the record date. Accordingly, the Cashed-Out Stockholders will retain the potential
upside value of the development efforts of the Company&rsquo;s LipimetiX Development, Inc. joint venture.</TD></TR></TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Given that many of the Cashed-Out Stockholders hold 200 or fewer shares, the brokerage fees to
sell such shares will be greater than the price of the shares. However, when the fractional interests are aggregated and sold by
Computershare, there will be brokerage fees, but those fees should be proportionally much less for the affected stockholders.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><IMG SRC="footer.jpg" ALT=""></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><IMG SRC="logo.jpg" ALT=""></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">With respect to the disclosure of timing constraints associated
with the Company&rsquo;s obligation to effect the sale of the aggregated fractional shares and to disburse the Cash-Out Payment,
the Company has added additional language on pages 4 and 12 of the Amended Proxy Statement to clarify that the Company expects
that its exchange agent will conduct the sale in an orderly fashion at a reasonable pace and that it may take several days to sell
all of the aggregated fractional shares of common stock.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">The Company notes to the Staff that the proposed reverse stock split is anticipated to
affect less than 400,000 shares of the Company&rsquo;s outstanding shares of common stock, or less than .7% of the shares outstanding,
and the affected shares have a market value, at market close on June 27, 2019, of less than $10,000. A holder of 999 shares, the
maximum amount for an individual holder that would become a Cashed-Out Stockholder, would have stock with a value at June 27, 2019
of less than $24 affected by the transaction.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">The Company further notes to the Staff that the Company has disclosed to stockholders
on pages 12 through 13 and 17 of the Amended Proxy Statement that if a particular stockholder does not hold sufficient shares of
pre-split common stock to receive at least one post-split share of common stock, such stockholder can purchase a sufficient number
of shares of common stock so that they would hold at least 1,000 shares of common stock prior to the implementation of the reverse
stock split. Thus, any potential Cashed-Out Stockholder has the opportunity to purchase a few more shares for an investment of
less than $24 to avoid the Cash-Out Payment.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">In light of the factors described above and the particular circumstances of the Company
and its business, the Board was able reasonably to conclude that the Cash-Out Payment is fair.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"><U>Trading Market and Price, page 19 </U></P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>7.</I></B></TD><TD><B><I>Please provide trading information for the first and second quarters of 2019. </I></B></TD></TR></TABLE>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-indent: -0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><B>Response</B>:<BR>
<BR>
</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">The Company respectfully acknowledges the Staff&rsquo;s comment and has added the additional
trading information on page 19 of the Amended Proxy Statement.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"><U>Form of Proxy<BR>
<BR>
</U></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>8.</I></B></TD><TD><B><I>Please revise the form of proxy to clearly identify it as being preliminary. Refer to Rule 14a-6(e)(1) of Regulation
14A.</I></B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><B>Response</B>:<BR>
<BR>
</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">The Company respectfully acknowledges the Staff&rsquo;s comment and has revised the form
of proxy included in the Amended Proxy Statement to identify it as being preliminary.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">* * *</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">Respectively submitted,</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><U>/s/ Les M. Taeger</U></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">Les M. Taeger</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">CFO</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;<IMG SRC="footer.jpg" ALT=""></P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>footer.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 footer.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  : JL# 2(  A$! Q$!_\0
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M6F\M6;!;RT(:3_=4YY]JYRZ\5:VNAV.J6ZV\EH;=IKRYM[(W"(%;!8#ST*@
M$E1O8<C'!HC!R5T%SNJ*YN;5M9M]:A40VEQ9744[PPQ@I*@C4%7:0L5*L3C[
MJ[=Z\G!SE6'BK6[O0-3NHTTVXO+.)961TEM3$#&6.Z-MS-@@8.55QG!&,T>S
M;U"YW-%4(-2C708M3O9(X8_LRSS.>%0;=Q/TJKX>\5Z)XJ@FFT6_6Z2!@DF$
M9"I(R,A@#@^O3@^E3RNUQFS17*+JGB'4=+DUG3'TQ;0%VAM)X9#)*BL1S*'
M0L ?X&QD=:P;_P =ZE(FI:A8V5Z+6TL;>>%0(?+<S+G,FX[^,\;<#Y3G.5JU
M2D]A7/2:*Y*Q\4/:SW-C?1:A)<P"W2*">* 3SR2"1@-T;^6>$/9 -I))SD.O
M/B!I.G7MO97T-Q;74NWS(9GA5X=SE%ROF9?)!/[O?QR>",KV<KV2"Z.KHKFO
M$WBJ+1+J"R61(II(GN))I())EAB0C<WEQ_,W7U  !)/ #5'\4:D=0$]O%:3:
M8VHG3EB4$2LVPD2"3=MP6&-NWISN[4*G)JX7.PHK$T2]U:74M2L=3^R2_91$
M4N+6)HT)<$M&0S-\RX4YSR'7@5%<ZCK=KXAM8!#:S65T9@L"(1-&$3(D9]VW
M:6PN-HQO7GM2Y7>P7.@HK@['QY/%I5U=:F;1YU^S+';QQ26[)+*2-C!BQ9!P
M1*H(89V@D8KJ]"U$:II,=Q]ICGDW,DC);O!AU8@J8W)92,8P>>_>G*$H[A<T
M:*X6S\1^)9;.\@GM0NL)%!-!;?V;MRCR;68?Z20V.>&:,KC+8%2MXCUZ3PV^
MI6JVCSVCO'<V\UFT;RRB3:(442MM;H VYP2RX%/V3"YVM%<D?$FI?VPC".U.
MF-J9TPQ[&\X,$SYF_=C&X8V[>G.>U7]=\:>'O#5Y;6FL:G':SW W1HR,W&<9
M)4$*,]S@<'T-+DE>R"YO45SGC#6+_1M-M+O3Y+<"2[B@D\RTDN#M=@N56-E)
M(SG SGI5)O&J:/H=E?:T1+]K<[)+>$6X"9P,I+)NW<_<4LW7CBA4Y-707.PH
MK%B\3V4^I2Z;'%<F^CN/)-NT>Q]O_/8!B/W7!^?H2,#)(!IZGXL@L_$<>DB:
M* 1^4US-)#)(!YC%40;>$R?XW(4948;)VI0DW:P7.FHKC++Q+K5Y<692&R:#
M5$N#9J$8- 8V 4R'=AP5.XX"D8QSUK<\/WVH7L%ZNHB!I;:[>W6>WC9(YU4#
MYE4LQ&"64C)Y0TW!K<+FO17":;XSO]1U9+&&339+FY%PJV:JPFL7C<*//^<[
M@1D]$/'&<Y%B3Q=>Z?9M!?+;O?R:A)96TT,$GE2A4W&01J7=MIW)L4DEEQE1
MDJ_92V"YV=%9T%])?Z##>:=+!<R3PJT4NTK&Q('S%2<@#J5SGC'6N=D\77NG
MV;07RV[W\FH265M-#!)Y4H5-QD$:EW;:=R;%))9<949*RH-[!<[.BN7F\4L[
MZ$-/:WNX;V6);BY"LJA71F&U2<ACM)P2=H'/458T[6[UM4UJ#5X[*UAL(XI0
MT4K.%1@Y)9V"]EST&.>3UI\C"YT%%<G#\1?#]_I%UJ.D2S:I':.BSQV\>R1-
MQP&(E*?+GO\ 7T-7?^$JADN6M[73KZZE2[-FZQB,;'$>\D[G'RXW#(SRI'ID
M]G);H+HWZ*Y>+QS92V:SC3]065K26[%NRQ^84C;:P^_MW=2%SG"GN,5*_C&V
MM[BXAO=.O[1H)((V,HC8$RG@C8[< ;BQZ *W7%'LY=@N='165#KT!TJ]U*\M
M[BPM[1Y$<W 4E@AP64(S9&00!U)'3IG/U'QE#I&DR:AJ6DZA:(DOE^7.T"%O
MEW;@QEV8YP!NW$Y !P:2A)Z(=SI:*Y:Z\=6EK<740TK5)Q;6L=Y))#'&5\AP
M3Y@RX/&T@KC=QP" 2&:CXV1+#6)M,T^ZN?L$,C"XPAA,BQ[P&&\.!SG)500#
M@G(R_9R["NCK**Y5?&T45DD]WI5^@BBCDOG41,MH'Z%L2$D$?-\FXA2,X/%2
M0>-K274!:2:;J-NOVQK%YY4C\N.4(7P2')P0.H! R,XH]G+L%T=-17 W7Q.L
M;G2;R?1(&N;F 0NBL\3AXWD"[L+)E.OW7VL"1D=<6;'Q9<6FN:C::C;ZE)";
M^WAC9HH<69G2,K&[*0&^=R/EWD<9/()?LI=4%T=K16+IOBBQU6Y2VM8KK[1Y
MCI/#)'L>V"]&D4D%0WR[>YW XP"03>);:*[GC%K=/:6I=;J^55\F!D0NRMEM
MYP,<JI&6 SG($\DMK#N;5%<K<>.K:SMYI;K2-5A:**.?RC'&S/"[;0Z[9"#@
MX!7.[D?+3[?QO:37Z6;Z;J4#_:Q9RM+&@6&5EW(&(<YW#!^7.,C=MS3]G+L*
MZ.GHHHJ!E34[$ZEIL]E]IFMA,NPRP!-X!Z@;E8<C(Z=^,'FL8>$76UTZWC\0
MZM&NGKMA(6V.>, L#"02!P#C]<FNDHJE)K8+&=#I$<5Q>7#W-S--=QK$TCL%
M9$4$ (5 V\EF^K'V 33='73YI+B6]NKZ[D58S<76S>$&2% 154#))Z9.>2<#
M&E12YF!FQZ'9IJ.H7I\QVOU5)8V;Y  H4X'8D!0?7:/2J9\*VZV&G6\%_?6\
M^GLS07<;(9?F!#;@RE&!SW7L",8K>HI\S"QAGPQ#+JUGJ-U?WET]G\T*3"(A
M7V!"X(0,"0,D!@I/.*M:)HT.AZ3%ID,\\]M"-L0GVDHG9!M49 ]\GU)K2HH<
MFU9A8PD\)V$>@66CK+<^19NKQR%P7.,\$XP05)4\?=..*AU#P;;:AK#:E_:-
M_;NTT-PT<)BV&2+A#\R%NF>,XY)QGFNCHHYY=Q6.4F\!VLZSL^K:E]HG>!GN
M0(/-80MNC4GROF 8*<MECM SC(,EWX+BN;U[I-:U.W9KP7P2(0%5F$?E[ANB
M)^[V)(KIZ*?M)=PLCC[CP8]AHD::7?7=Q>6-M=1VBW)AVR><!E'Q'C&Y01T/
MJ<50T'PA/_9UYI4T5[I^CR)&R0RI9I,+A6#>8# NT@!4Y?))!R,=>_HI^UE:
MP6.=3PA;I<M*=2U!XWF6Y:!C&8S<  "7&S(;(#8!"[N=M&F^$(-,.FF/4[^0
MV#S-&9/*^82D%E;$8XR,C&#SUQQ7145//+N%C(GT$75]YUQJ-[+:^:LWV%BA
MAWJ05.=F_ 8!L;L9[8XJ@/!5NEY;3PZKJ,4=M?27T5NODE%DDW;QDQEB#O?^
M+^+@\#'344*<D%CGCX1MF@OK0W]^=.NS(S6.Y!'&SG<S(P3>/F)8#=@$].F)
M)_#37-I;1W&LZC/<6MR+FWNG\D.C!2N,",(1AFZJ3\W7@8W:*.>06,JUTJY7
M0A9W&HW*W;DR/<Q299'+[\*7!&T'@ C&T8Q5.?PE!<6P$FHWYO1<I=?;\Q><
M70;5XV>7@*<8V8ZGJ2:Z&BCG8['*VG@6WLY;-TUC5'2TN9KE(W,)!:7.\,?+
MW$'<W?/S'GIB2S\%PZ<MJ++6-3MVMH!:JZF$EH <K&V8R,+S@XW?,<L:Z:BG
M[23ZBLC*U_0E\06*6<E_=VD2RI*?LWEY8HP=<[T;HR@\8Z<Y%5SX6MFU47TE
MY=R;GBFF@8IY<TT:A4E8!<A@ OW2%^4<<5NT4E)I60[&/I6@?V5J>H7_ /:=
M[=/?.))8YQ%M#!54$;$4C"J!U_7FH7\%^'7\2KXB;2XCJJG<)]S=<8SMSM)Q
MWQFMZBCGEO<+&7KNBKKMK#;M?75H(IX[@-;>7DNC!ESO1A@, >G;TXIDN@JV
ML'4[?4;VUED5$N(X3&4N A.-P9"0<$C*%3COP,:]%"DUH!R]KX*CM;ZTNAK>
MJ2-;7<MVJN(-K/+G?G$0.#N;H1C=QCC&1#X1O;'Q'IMG:3ZNFE6VGRVIO5>V
MR0SJPC((W;<*1D*&R1SU-=_15*K(5C"@\,PZ=>&YTJZN;2/9&K6,;(()3&H1
M-Q9&9?E"J=I'"C@]WMH,UQX832+G5+P2M&%GNHF4NY/+#YPWRDDC'8<5M45/
M.QV,C4-":_O;6[75K^UFMX9(E, B^8.!DG=&><JIQP,J.*JZ9X4.F+9Q#7-3
MN+6U;>EO,MOM9N>6*Q!F.26)W9)Y.:Z&BCG=K!8H:KI:ZI%"/M-Q:S6\HFAG
MMRN^-L%20&#*<JS#!!Z^O-9J^$;=;46@U'4/LKAA=PF1"MV69F<R97(+%FSL
M*Y! Z  =#10I-:(+'/R>%5FO+Z6;5]1DM[Y#%/:,(?+,>TJ(P1'O50&.,,.2
M3DDG+6\(I)9W\4VL:E-<7L*V\MVYA,HA&?W:CR]@'S-D[<G=UX&.BHHYY"L9
M]MI$,6AKI-U))?VXB,+&Z5"9$Z88*JKTXZ=!SD\U6\/>%-$\*P30Z+8+:I.P
M>3#LY8@8&2Q)P/3IR?6MFBES/:XSGAX2@3SX;?4]1M].N)&>33XG01'=RX4E
M#(@)R<*X')QC-07O@>UO#J:_VIJ$$.H)'')#"( B)']Q4S&2 !QU-=115<\N
MXK'+W'@F"ZU":_EUC4S=2&%UD!A!B>+.QUQ'C.&<$'((<\=,7%\-LE^E\FLZ
MDER8TCN77R?]*522N\>7@'YB,H%.#]*W**7/+N%C'U?P[!J]PL[7=U:N8'MI
M3;E!YT+$%D;<IP..JX89."*@C\(V4%\;B"YNHHA*;B.U4H8HIO+\OS%RI.0O
M8DKGG;GFM^BCGDE:X['/V?A&TBM7M-1NIM9M6;S/)U*&"10^22_$8);D\DFE
M/A5#?SSG5;_[//&(7L@L(A$0! C7$>]5P3T8'WK?HHYY=Q6.:_X0RV9-T^IZ
MC/=J(E@NY&C\R 1MN0* @4\DY+*2>AR,59@\):/$@>6TCN;P,[_;IHU-QO8D
ME@X V'))&W '8"MRBCGEW"QA)X:*H\AUK4VOVV@7Q,7FJBYP@41^65^9LY0Y
MSDG(7$<WA-6^R_9]8U*U-NS2DQ>2WFRL26D??&P+')Z8 [ 5T-%'/(+&'#X7
MM8=4%\;N[D43_:OLSE/*\_R_+,O"ALD9XSMR<[<\TFN^#/#WB:[MKK6-,BNI
M[88C=F93C.<':1N&>QR.3ZFMVBCGE>]PL9.N:$FN6]M";ZZLUMITG0VHCR70
MY7.]&& 1G'YU4\0^$+3Q%,TL]]>VQDMC:R"V,8WQE@V"61B.0#P1G'.:Z&BA
M3DMAV,>+P[#'?)J!O+M[\-\UTS)N>/\ YY$!=HCXZ #G)SDDEE_X8M-0U&2Z
MDN;J-)A%]IMHROEW'EMN3=E2PP?[K#( !R*VZ*.9A8YV+PA;VYE\C4M0B^25
M+;:T?^AB5PS^62F>2!RV[ X&*EM?"EA':0VVH_\ $W2W(-N=0MX&,'^[MC7K
M@<G)]ZW:*.>7<5C)ET(2R7D[:C>BZN$,4=PIC#VT9.=D7R8 SW(+' R3@8IQ
M^$O+M;6(:WJ7FV;[K:XVVX>(%2I4 1;2"#SN4G/.:Z*BCGD.QA1^$=(MK01V
M-NEG=K#Y*ZA#&ANE7&"1(RDYQW-11^$O+M;6(:WJ7FV;[K:XVVX>(%2I4 1;
M2"#SN4G/.:Z*BCGEW%8Y"\^&V@73V#I%]G>S*L'CMX'>8J, R/)&S-Q[X_(8
MU+?PU%#J^HW\U_=W2Z@NR>UN$A,)49"K@1@X )').0><UMT4W4D]V%D<[IG@
M7PYHNF:AI^FZ:MO!J$9BN<2,[.I4KC+$G&">.G-7;+P_96&HB^B,IF^S);'<
MV0P4D[SQRYSRW>M6BDYR>['8P_\ A$],\Z.4"4,E\U\/F'WVW;EZ?<)=FV^I
MS4NI>'+#5;F>>Y$A>>T:T?:PQM.<,..&&YL'MN/K6O11S2[A8RKO0+:]TI=+
MEFG^P^0T$L(*_O01C+-C=N'7((Y/.:S;SP8NH0P)=Z]JTTD*2Q+,WD!_+D4*
MZ9$6.0OWL;N3S73T4*<EL*QP5OX4NW\4W-M.=431AID%D9C);[;Q4+Y5P!O
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9QB+&-H (.>@[Y)ZBBG[27<5D%%%%0,__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !, -0# 2(  A$! Q$!_\0
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M10!XQ\7F+?$?X?QRG]Q]L!YZ9\V//]*]E[UYA\;M NM0\+6NMZ>I:\T2?[2
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D:QN8[>SF>5WF8;0SED48"EL =S^75#I3:<.E)NX!1112 __9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
